Endoscopy 2000; 32(12): 935-942
DOI: 10.1055/s-2000-9627
Original Article
© Georg Thieme Verlag Stuttgart · New York

Management in Peptic Ulcer Hemorrhage:A Dutch National Inquiry

M.  E.  van Leerdam1 , , E.  A.  J.  Rauws1 , , A.  A.  M.  Geraedts2 , , G.  N.  J.  Tytgat1
  • 1 Dept. of Gastroenterology, Academic Medical Center, Amsterdam, The Netherlands
  • 2 Dept. of Gastroenterology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Background and Study Aims: There is no consensus as to what endoscopic hemostatic therapy and pharmacotherapy should be used in peptic ulcer hemorrhage (PUH). We conducted a mail survey to investigate current management of ulcer hemorrhage in the Netherlands.

Methods: A questionnaire was sent to gastroenterologists or, if not present, to internists, performing endoscopies, in every hospital in the Netherlands (n = 123). Endoscopic hemostatic therapy, pharmacotherapy, endoscopic reintervention, and management of Helicobacter pylori were evaluated.

Results: 90/123 (73 %) questionnaires were returned. Endoscopic hemostatic therapy is given in ulcers classified as Forrest Ia, Ib, IIa, IIb, and IIc by, respectively, 89 %, 93 %, 83 %, 47 %, and 19 % of respondents. Gastroenterologists perform endoscopic therapy more often in Forrest Ib (P = 0.03), IIa (P = 0.002), and IIb (P = 0.001) ulcers when compared with internists. Endoscopic injection therapy is used by 93 % of respondents as first modality. Epinephrine combined with polidocanol is most commonly used (60 %). Pharmacotherapy is given by 97 %. A total of 71 % use proton pump inhibitors (PPIs), and 26 % use H2-receptor antagonists (H2RAs), both mainly initially given intravenously. In case of suspected rebleeding, endoscopic reintervention is performed by 76 %, including a significantly greater percentage of gastroenterologists (89 % of gastroenterologists vs. 60 % of internists, P = 0.005), whereas the others refer the patient directly for surgery. Almost all respondents investigate for H. pylori. Eradication is confirmed by only 64 % (80 % of gastroenterologists vs. 50 % of internists, P = 0.004).

Conclusions: There are important differences in management of peptic ulcer hemorrhage between gastroenterologists and internists in the Netherlands. Management is only partly in accordance with evidence-based medicine.

References

  • 1 Vreeburg E M, Snel P, de Bruijne J W, et al. Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome.  Am J Gastroenterol. 1997;  92 236-243
  • 2 Hui W M, Ng M M, Lok A S, et al. A randomized comparative study of laser photocoagulation, heater probe, and bipolar electrocoagulation in the treatment of actively bleeding ulcers.  Gastrointest Endosc. 1991;  37 299-304
  • 3 Laine L, Peterson W L. Bleeding peptic ulcer.  N Engl J Med. 1994;  331 717-727
  • 4 Jaramillo J L, Galvez C, Carmona C, et al. Prediction of further hemorrhage in bleeding peptic ulcer.  Am J Gastroenterol. 1994;  89 2135-2138
  • 5 Rockall T A, Logan R F, Devlin H B, et al. Risk assessment after acute upper gastrointestinal haemorrhage.  Gut. 1996;  38 316-321
  • 6 Brullet E, Campo R, Calvet X, et al. Factors related to the failure of endoscopic injection therapy for bleeding gastric ulcer.  Gut. 1996;  39 155-158
  • 7 Skok P. How efficient is endoscopic injection sclerotherapy in peptic ulcer hemorrhage.  Hepatogastroenterology. 1997;  44 861-865
  • 8 Villanueva C, Balanzo J. A practical guide to the management of bleeding ulcers.  Drugs. 1997;  53 389-403
  • 9 Kubba A K, Palmer K R. Role of endoscopic injection therapy in the treatment of bleeding peptic ulcer.  Br J Surg. 1996;  83 461-468
  • 10 Cook D J, Guyatt G H, Salena B J, et al. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis.  Gastroenterology. 1992;  102 139-148
  • 11 NIH Consensus C onference. Therapeutic endoscopy and bleeding ulcers.  JAMA. 1989;  262 1369-1372
  • 12 ASGE Standards of Practice C ommittee. The role of endoscopy in the management of non-variceal acute upper gastrointestinal bleedings. Guidelines for clinical application.  Gastrointest Endosc. 1992;  38 760-764
  • 13 Lin H J, Lo W C, Lee F Y, et al. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy.  Arch Intern Med. 1998;  158 54-58
  • 14 Hasselgren G, Lind T, Lundell L, et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study.  Scand J Gastroenterol. 1997;  32 328-333
  • 15 Schaffalitzky de Muckadell O B, Havelund T, Harling H, et al. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study.  Scand J Gastroenterol. 1997;  32 320-327
  • 16 Daneshmend T K, Hawkey C J, Langman M J, et al. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial.  BMJ. 1992;  304 143-147
  • 17 Forrest J A, Finlayson N D, Shearman D J. Endoscopy in gastrointestinal bleeding.  Lancet. 1974;  2 394-397
  • 18 Cooper G S, Chak A, Way L E, et al. Early endoscopy in upper gastrointestinal hemorrhage: associations with recurrent bleeding, surgery, and length of hospital stay.  Gastrointest Endosc. 1999;  49 145-152
  • 19 Saeed Z A, Ramirez F C, Hepps K S, et al. Prospective validation of the Baylor bleeding score for predicting the likelihood of rebleeding after endoscopic hemostasis of peptic ulcers.  Gastrointest Endosc. 1995;  41 561-565
  • 20 Vreeburg E M, Terwee C B, Snel P, et al. Validation of the Rockall risk scoring system in upper gastrointestinal bleeding.  Gut. 1999;  44 331-335
  • 21 Laine L, Freeman M, Cohen H. Lack of uniformity in evaluation of endoscopic prognostic features of bleeding ulcers.  Gastrointest Endosc. 1994;  4 411-417
  • 22 Freeman M L, Cass O W, Peine C J, et al. The non-bleeding visible vessel versus the sentinel clot: natural history and risk of rebleeding.  Gastrointest Endosc. 1993;  39 359-366
  • 23 Mondardini A, Barletti C, Rocca G, et al. Non-variceal upper gastrointestinal bleeding and Forrest's classification: diagnostic agreement between endoscopists from the same area.  Endoscopy. 1998;  3 508-512
  • 24 Lau J Y, Leung J W. Injection therapy for bleeding peptic ulcers.  Gastrointest Endosc Clin N Am. 1997;  7 575-591
  • 25 Beckly D E, Casebow M P. Prediction of rebleeding from peptic ulcer experience with an endoscopic Doppler device.  Gut. 1986;  27 96-99
  • 26 Kohler B, Maier M, Benz C, et al. Acute ulcer bleeding. A prospective randomized trial to compare Doppler and Forrest classifications in endoscopic diagnosis and therapy.  Dig Dis Sci. 1997;  42 1370-1374
  • 27 Kohler B, Riemann J F. Endoscopic injection therapy of Forrest II and III gastroduodenal ulcers guided by endoscopic Doppler ultrasound.  Endoscopy. 1993;  25 219-223
  • 28 Fullarton G M, Murray W R. Prediction of rebleeding in peptic ulcers by visual stigmata and endoscopic Doppler ultrasound criteria.  Endoscopy. 1990;  22 68-71
  • 29 Wong R CK, Chak A, Kobayashi K, et al. Role of doppler ultrasound in acute peptic ulcer hemorrhage: can it predict failure of endoscopic treatment [abstract]?.  Gastrointest Endosc. 1999;  49 AB 170
  • 30 Grosso C, Rossi A, Gambitta P, et al. Non-bleeding visible vessel treatment: perendoscopic injection therapy versus omeprazole infusion.  Scand J Gastroenterol. 1995;  3 872-875
  • 31 Bleau B L, Gostout C J, Shaw M J, et al. Final results: rebleeding from peptic ulcers associated with adherent clots: a prospective randomized controlled study comparing endoscopic therapy with medical therapy [abstract].  Gastrointest Endosc. 1997;  45 AB 87
  • 32 Mallery S, Freeman M L, Cass O W, et al. Rebleeding from gastroduodenal peptic ulcers in the age of endoscopic therapy [abstract].  Gastrointest Endosc. 1996;  43 353
  • 33 Chung S C, Leung J W, Steele R J, et al. Endoscopic injection of adrenaline for actively bleeding ulcers: a randomised trial.  Br Med J. 1988;  296 1631-1633
  • 34 Lin H J, Perng C L, Lee F Y, et al. Endoscopic injection for the arrest of peptic ulcer hemorrhage: final results of a prospective, randomized comparative trial.  Gastrointest Endosc. 1993;  39 15-19
  • 35 Pulanic R, Vucelic B, Rosandic M, et al. Comparison of injection sclerotherapy and laser photocoagulation for bleeding peptic ulcers.  Endoscopy. 1995;  27 291-297
  • 36 Llach J, Bordas J M, Salmeron J M, et al. A prospective randomized trial of heater probe thermocoagulation versus injection therapy in peptic ulcer hemorrhage.  Gastrointest Endosc. 1996;  43 117-120
  • 37 Chung S S, Lau J Y, Sung J J, et al. Randomised comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcers.  BMJ. 1997;  314 1307-1311
  • 38 Chung S C, Leung J W, Sung J Y, et al. Injection or heat probe for bleeding ulcer.  Gastroenterology. 1991;  1 33-37
  • 39 Villanueva C, Balanzo J, Espinos J C, et al. Endoscopic injection therapy of bleeding ulcer: a prospective and randomized comparison of adrenaline alone or with polidocanol.  J Clin Gastroenterol. 1993;  17 195-200
  • 40 Chung S C, Leung J W, Leong H T, et al. Adding a sclerosant to endoscopic epinephrine injection in actively bleeding ulcers: a randomized trial.  Gastrointest Endosc. 1993;  39 611-615
  • 41 Lin H J, Perng C L, Lee S D. Is sclerosant injection mandatory after an epinephrine injection for arrest of peptic ulcer haemorrhage. A prospective, randomised, comparative study.  Gut. 1993;  34 1182-1185
  • 42 Choudari C P, Palmer K R. Endoscopic injection therapy for bleeding peptic ulcer; a comparison of adrenaline alone with adrenaline plus ethanolamine oleate.  Gut. 1994;  35 608-610
  • 43 Chung S C, Leong H T, Chan A C, et al. Epinephrine or epinephrine plus alcohol for injection of bleeding ulcers: a prospective randomized trial.  Gastrointest Endosc. 1996;  43 591-595
  • 44 Kubba A K, Lessells A, Palmer K R. Experimental studies of injection therapy for ulcer haemorrhage in rabbits.  Br J Surg. 1997;  84 551-554
  • 45 Rutgeerts P, Geboes K, Vantrappen G. Experimental studies of injection therapy for severe nonvariceal bleeding in dogs.  Gastroenterology. 1989;  97 610-621
  • 46 Loperfido S, Patelli G, La Torre L. Extensive necrosis of gastric mucosa following injection therapy of bleeding peptic ulcer.  Endoscopy. 1990;  22 285-286
  • 47 Lee J G, Lieberman D A. Complications related to endoscopic hemostasis techniques.  Gastrointest Endosc Clin N Am. 1996;  6 305-321
  • 48 Rutgeerts P, Rauws E, Wara P, et al. Randomised trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer.  Lancet. 1997;  35 692-696
  • 49 Kubba A K, Murphy W, Palmer K R. Endoscopic injection for bleeding peptic ulcer: a comparison of adrenaline alone with adrenaline plus human thrombin.  Gastroenterology. 1996;  111 623-628
  • 50 Lin H J, Tseng G Y, Perng C L, et al. Comparison of adrenaline injection and bipolar electrocoagulation for the arrest of peptic ulcer bleeding.  Gut. 1999;  44 715-719
  • 51 Jensen D M, Smith J, Savides T J, et al. Randomized controlled study of combination epinephrine injection and gold probe compared to gold probe alone for hemostasis of actively bleeding peptic ulcers [abstract].  Gastrointest Endosc. 2000;  51 AB 130
  • 52 Jensen D M, Kovacs T O, Jutabha R, et al. Randomized, prospective study of bipolar coagulation alone compared to combination epinephrine injection and bipolar coagulation for prevention of rebleeding from ulcers with non-bleeding visible vessels [abstract].  Gastrointest Endosc. 2000;  51 AB 130
  • 53 Rutgeerts P, Vantrappen G, Broeckaert L, et al. Comparison of endoscopic polidocanol injection and YAG laser therapy for bleeding peptic ulcers.  Lancet. 1989;  1 1164-1167
  • 54 Green F W, Jr., Kaplan M M, Curtis L E, et al. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage.  Gastroenterology. 1978;  74 38-43
  • 55 Patchett S E, Enright H, Afdhal N, et al. Clot lysis by gastric juice: an in vitro study.  Gut. 1989;  3 1704-1707
  • 56 Kiilerich S, Rannem T, Elsborg L. Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer.  Digestion. 1995;  56 25-30
  • 57 Teyssen S, Chari S T, Scheid J, et al. Effect of repeated boluses of intravenous omeprazole and primed infusions of ranitidine on 24-hour intragastric pH in healthy human subjects.  Dig Dis Sci. 1995;  4 247-255
  • 58 Reynolds J R, Walt R P, Clark A G, et al. Intragastric pH monitoring in acute upper gastrointestinal bleeding and the effect of intravenous cimetidine and ranitidine.  Aliment Pharmacol Ther. 1987;  1 23-30
  • 59 Brunner G, Luna P, Hartmann M, et al. Optimizing the intragastric pH as a supportive therapy in upper GI bleeding.  Yale J Biol Med. 1996;  69 225-231
  • 60 Netzer P, Gaia C, Sandoz M, et al. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.  Am J Gastroenterol. 1999;  94 351-357
  • 61 Brunner G, Chang J. Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: an open randomized controlled trial.  Digestion. 1990;  45 217-225
  • 62 Coraggio F, Rotondano G, Marmo R, et al. Somatostatin in the prevention of recurrent bleeding after endoscopic haemostasis of peptic ulcer haemorrhage: a preliminary report.  Eur J Gastroenterol Hepatol. 1998;  1 673-676
  • 63 Khuroo M S, Yattoo G N, Javid G, et al. A comparison of omeprazole and placebo for bleeding peptic ulcer.  N Engl J Med. 1997;  336 1054-1058
  • 64 Saeed Z A, Cole R A, Ramirez F C, et al. Endoscopic retreatment after successful initial hemostasis prevents ulcer rebleeding: a prospective randomized trial.  Endoscopy. 1996;  28 288-294
  • 65 Lin C K, Lai K H, Lo G H, et al. The value of second-look endoscopy after endoscopic injection therapy for bleeding peptic ulcer [abstract].  Gastroenterology. 1996;  11 AB177
  • 66 Messmann H, Schaller P, Andus T, et al. Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial.  Endoscopy. 1998;  3 583-589
  • 67 Villanueva C, Balanzo J, Torras X, et al. Value of second-look endoscopy after injection therapy for bleeding peptic ulcer: a prospective and randomized trial.  Gastrointest Endosc. 1994;  4 34-39
  • 68 Lau J Y, Sung J J, Lam Y H, et al. Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers.  N Engl J Med. 1999;  34 751-756
  • 69 European Helicobacter Pylori Study G roup. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report.  Gut. 1997;  41 8-13

M. E. van Leerdam,M.D. 

Dept. of Gastroenterology


Academic Medical Center

Meibergdreef 9 1105 AZ

Amsterdam The Netherlands

Fax: Fax:+ 31-20-6917033

Email: E-mail:m. e.vanleerdam@amc.uva.nl

    >